Influence of anthracycline-based chemotherapy on menstruation of patients with breast cancer
10.3760/cma.j.issn.1006-9801.2011.07.006
- VernacularTitle:蒽环类药物对乳腺癌患者月经状态的影响
- Author:
Yongfeng LI
;
Yunfei WU
- Publication Type:Journal Article
- Keywords:
Breast cancer;
Adjuvant chemotherapy;
Anthracycline;
Amenorrhea
- From:
Cancer Research and Clinic
2011;23(7):453-455
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the influence of aging and chemotherapeutic drugs of breast cancer patients on chemotherapy-induced amenorrhea (CIA) and to guide the further selection of drugs for chemotherapy.Methods We prospectively studied the CIA of the premenopausal breast cancer patients and compared the difference in CIA between the patients who were at different aging periods or received different chemotherapeutics. Results 137 patients were followed up.The occurrence rate of CIA and long-term chemotherapy-induced amenorrhea(LCIA)were 73.72%(101/137)and 43.80%(60/137)respectively.The rate of CIA and LCIA was significandy higher in older women(＞40 years)than young women(≤40 years,X2=25.32,18.42,P＜0.05).The recovery rate of CIA in young women was 61.90%(13/21)which was significantly higher than the older women[35.00%(28/80);X2=4.99,P=0.025].The difference in the rate of LCIA was statistically significant between the older women (＞40 years)who received different anthracyclinebased chemotherapy(X2=6.92,P=0.031).Conclusion Age is an important factor for the CIA.Chemotherapy has less influence on the menstruation of younger women(≤40) and most amenorrhea is reversible.For older women,the rate of LCIA is different in patients who receive imported epirubicin,domestic epirubicin or pirarubicin.
